Subject to change.
Subject to change.
Luiza Moore, Senior Director of Clinical Diagnostics in AstraZeneca's Oncology Business Unit, brings 15+ years of expertise in pathology, genomics and precision diagnostics. She leads the development and deployment of computational pathology solutions that match patients with the right medicines. By advancing global access to cutting‑edge diagnostics, she aims to translate technology into improved patient outcomes and broader therapeutic access.